Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

1.
2.

[Mineralocorticoid receptor antagonists and therapeutic strategies of cardiovascular damage].

Verdugo FJ, Montellano FA, Carreño JE, Marusic ET.

Rev Med Chil. 2014 Jan;142(1):61-71. doi: 10.4067/S0034-98872014000100010. Review. Spanish.

3.

The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM Registry.

Garcia-Rubira JC, Calvo-Taracido M, Francisco-Aparicio F, Almendro-Delia M, Recio-Mayoral A, Reina Toral A, Aramburu-Bodas O, Gallego García de Vinuesa P, Cruz Fernández JM, Alcántara AG, Hidalgo-Urbano R.

Intern Emerg Med. 2014 Oct;9(7):759-65. doi: 10.1007/s11739-013-1032-9. Epub 2013 Dec 19.

PMID:
24352793
4.

The sympathetic nervous system and heart failure.

Zhang DY, Anderson AS.

Cardiol Clin. 2014 Feb;32(1):33-45, vii. doi: 10.1016/j.ccl.2013.09.010. Review.

PMID:
24286577
5.

Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.

Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):243-51. doi: 10.1161/CIRCEP.112.977777. Epub 2013 Feb 12.

6.

[Atrial fibrillation after coronary artery bypass surgery: possibilities of prevention].

Obrenović-Kirćanski B, Orbović B, Vraneš M, Parapid B, Kovačević-Kostić N, Velinović M, Ristić S.

Srp Arh Celok Lek. 2012 Jul-Aug;140(7-8):521-7. Review. Serbian.

PMID:
23092042
7.

Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation.

Jang SJ, Kim MS, Park HJ, Han S, Kang DH, Song JK, Park SW, Park SJ, Kim JJ.

Heart. 2013 Jan;99(1):17-21. doi: 10.1136/heartjnl-2012-301980. Epub 2012 Sep 2.

PMID:
22942291
8.

Prevalence and predictors of ventricular remodeling after anterior myocardial infarction in the era of modern medical therapy.

Farah E, Cogni AL, Minicucci MF, Azevedo PS, Okoshi K, Matsubara BB, Zanati SG, Haggeman R, Paiva SA, Zornoff LA.

Med Sci Monit. 2012 May;18(5):CR276-81.

9.

Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF.

Wilcox JE, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Gheorghiade M.

Am Heart J. 2012 Jan;163(1):49-56.e2. doi: 10.1016/j.ahj.2011.10.001.

PMID:
22172436
10.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

11.
12.

Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.

Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):700-8. doi: 10.1002/pds.2146. Epub 2011 May 14.

PMID:
21608070
13.

Gender differences in cardiac rehabilitation programs from the Italian survey on cardiac rehabilitation (ISYDE-2008).

De Feo S, Tramarin R, Ambrosetti M, Riccio C, Temporelli PL, Favretto G, Furgi G, Griffo R.

Int J Cardiol. 2012 Oct 4;160(2):133-9. doi: 10.1016/j.ijcard.2011.04.011. Epub 2011 Apr 30.

PMID:
21531469
14.

Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.

de Peuter OR, Lip GY, Souverein PC, Klungel OH, de Boer A, Büller HR, Kamphuisen PW.

Eur J Heart Fail. 2011 May;13(5):489-95. doi: 10.1093/eurjhf/hfq228. Epub 2010 Dec 29.

PMID:
21193438
15.

[Digoxin: the results of the DIG study in the XXI century].

Helber I, Tucci PJ.

Arq Bras Cardiol. 2010 Oct;95(4):e108-11. Multiple languages.

16.

Pharmacologic management of heart failure with preserved ejection fraction.

Huang D, Cheng JW.

Ann Pharmacother. 2010 Dec;44(12):1933-45. doi: 10.1345/aph.1P372. Epub 2010 Nov 23. Review.

PMID:
21098754
17.

Pharmacotherapy and hospital admissions before out-of-hospital cardiac arrest: a nationwide study.

Weeke P, Folke F, Gislason GH, Lippert FK, Olesen JB, Andersson C, Fosbøl EL, Charlot MG, Kanters JK, Poulsen HE, Nielsen SL, Køber L, Torp-Pedersen C.

Resuscitation. 2010 Dec;81(12):1657-63. doi: 10.1016/j.resuscitation.2010.06.025. Epub 2010 Aug 19.

PMID:
20727660
18.

[Is there circadian variation of big endothelin and NT-proBNP in patients with severe congestive heart failure?].

Ludka O, Spinar J, Pozdísek Z, Musil V, Spinarová L, Vítovec J, Tomandl J.

Vnitr Lek. 2010 Jun;56(6):488-93. Czech.

PMID:
20681460
19.

[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure].

Lopukhova VV, Sapel'nikov OV, Grishin IR, Erastova NV, Latypov RS, Mareev IuV, Chernova NA, Saidova MA, Akchurin RS, Karpov IuA.

Kardiologiia. 2010;50(7):91-5. Russian. No abstract available.

PMID:
20659052
20.

Multiple embolisations in rheumatic heart disease: a case report.

Isezuo SA, Musa AA, Saidu SA.

West Afr J Med. 2009 Jul-Aug;28(4):274-6.

PMID:
20425747
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk